|
2025
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations,
namely, anti-infective preparations an... |
|
|
Invention
|
Bispecific antibody that is effective for t-cell tumor patients with t-cell dysfunction. The pres... |
|
|
Invention
|
Bispecific antibody effective for patients with malignant tumors other than t-cell tumors. The pr... |
|
2024
|
Invention
|
Crystalline forms of diazabicyclooctane derivative and production process thereof.
A crystalline... |
|
|
Invention
|
Neuroprotective agent. Provided are: a novel compound that is useful for the treatment of disease... |
|
|
Invention
|
Novel anti-truncated mutant calr-cd3 bispecific antibody and pharmaceutical composition. The pres... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infective preparations and substances for medical purpo... |
|
2023
|
Invention
|
Avermectin derivative. A compound represented by general formula (I): [in formula (I), n represen... |
|
|
Invention
|
Therapeutic agent for t cell tumor. The present invention addresses the problem of providing a no... |
|
|
Invention
|
Processes for preparing a diazabicyclooctane compound. A process for preparing a diazabicycloocta... |
|
|
Invention
|
Medicine comprising combination of anti-mutant-calr antibody and another drug.
A pharmaceutical ... |
|
|
Invention
|
Medicine comprising combination of anti-mutant-calr antibody and another drug. The purpose of the... |
|
2022
|
Invention
|
Crystalline forms of diazabicyclooctane derivative and production process thereof. A crystalline ... |
|
|
Invention
|
Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and ... |
|
|
Invention
|
Mesostigmata mite control agent. A control agent comprising, as an active ingredient, a specific ... |
|
|
Invention
|
Anti-human pd-1 agonist antibody and pharmaceutical composition comprising the antibody for treat... |
|
|
Invention
|
Anti-human pd-1 agonist antibody for treating or preventing inflammatory diseases, and pharmaceut... |
|
2021
|
Invention
|
Anti-cleaved mutant calr-cd3 bispecific antibody and pharmaceutical composition.
A bispecific an... |
|
|
Invention
|
Anti-truncated mutant calr-cd3 bispecific antibody and pharmaceutical composition. Provided are: ... |
|
|
Invention
|
Method and kit for promoting expression of target protein in mammalian cells, and utilization the... |
|
|
Invention
|
Pd-1 agonist-containing pharmaceutical composition for treating or preventing th2-mediated diseas... |
|
|
Invention
|
Novel bicyclic compound. Provided are: a novel compound, and a pharmaceutically acceptable salt t... |
|
|
Invention
|
Agent for use with bacteriophage. A composition for lysing at least one type of staphylococcus ba... |
|
2020
|
Invention
|
Pharmaceutical composition comprising steroid compound and olopatadine. The present invention rel... |
|
|
Invention
|
Method for separating cell from biological tissue.
Provided is a method for efficiently and stab... |
|
|
Invention
|
Bacteriophage composition. A composition for lysing Staphylococcus aureus or a composition for pr... |
|
|
Invention
|
Novel triazine derivative. Provided is a compound represented by the following formula (1) and a ... |
|
|
Invention
|
Agent for controlling scald disease and method for controlling scald disease. An agent for contro... |
|
|
Invention
|
Agent for suppressing bitterness in asenapine, and method for suppressing bitterness. The purpose... |
|
|
Invention
|
Flupyrimin-containing solid formulation for rice pest control. Provided is a solid formulation fo... |
|
|
Invention
|
Plant parasitic nematode controlling agent and plant parasitic nematode controlling method. This ... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
the treatment of osteoarthritis and... |
|
|
Invention
|
Antibodies that bind to cleaved form of mutant calreticulin, and diagnostic, preventive, or thera... |
|
|
Invention
|
Antibody capable of binding to truncated mutant calreticulin, and diagnostic, prophylactic or the... |
|
|
Invention
|
Bacteriophage composition. This composition for lysis of Staphylococcus aureus or this compositio... |
|
|
Invention
|
Effective aminoglycoside antibiotic for multidrug-resistant bacteria. A compound represented by t... |
|
2019
|
Invention
|
Bacteriophage composition. This composition is for lysing Staphylococcus aureus or treating or pr... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritis and ... |
|
|
Invention
|
Aqueous suspension-type pesticide composition. 122 represents a C1-6 alkyl group substituted with... |
|
|
Invention
|
Mesostigmata mite control composition. A Mesostigmata mite control composition comprising, as act... |
|
|
Invention
|
Composition for controlling mesostigmata mites. A composition for controlling mesostigmata mites ... |
|
|
Invention
|
Plant disease control agent. The present invention provides a plant disease control agent which c... |
|
|
Invention
|
Plant disease control agent. Provided are a plant disease control agent and a plant disease contr... |
|
|
G/S
|
Antibiotics; |
|
|
Invention
|
Bacteriophage preparation.
It has been found that a bacteriophage specified by accession number ... |
|
|
Invention
|
Bacteriophage preparation. Staphylococcus hyicusStaphylococcus chromogenesStaphylococcus chromoge... |
|
|
Invention
|
Therapeutic agent for inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer d... |
|
|
Invention
|
Crystal of benzoxazole derivative. Provided are crystals of 1-((2-(3,6-diazabicyclo[3.1.1]heptan-... |
|
2018
|
Invention
|
Aqueous formulation and in-syringe aqueous formulation, and antibody protein deaggregation agent ... |
|
|
Invention
|
Mesostigmata mite control agent.
A control agent comprising, as an active ingredient, a specific... |
|
2010
|
G/S
|
Pharmaceutical preparations. Medical apparatus and instruments. |
|
2009
|
G/S
|
Antimicrobial agents for medical purposes; drugs for medical
purposes. |
|
2008
|
G/S
|
Pharmaceutical preparations, namely antibacterial preparations. |
|
|
G/S
|
Antibiotics. |
|
|
G/S
|
Antibiotics for animal use. |
|
|
G/S
|
Analgesics for animal use. |
|
2007
|
G/S
|
Pharmaceutical preparations, antibiotics. |
|
2005
|
G/S
|
Pharmaceutical preparations, including articular function improving agents. |
|
|
G/S
|
Prepackaged injectable medicine; prepackaged injectable sodium hyaluronate solutions. Medical app... |
|
1999
|
G/S
|
Pharmaceutical preparations. |
|
1997
|
G/S
|
Veterinary preparations, additives for animal feeds. |
